Posdoctoral researcher - Neurofibromatosis research group
REF: 24-114_MS_CL
About the research group
We are a multidisciplinary research group working on Hereditary Cancer at the Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL). Our work, whether clinical- or research-oriented, is focused on the improvement of healthcare of patients with a personal or a family history of cancer.
The overarching goal of our research activity is to gain insight into the molecular bases of hereditary cancer -with a particular interest in gastrointestinal cancer, Hereditary Breast and Ovarian Cancer and Rare Tumor predisposing syndromes – to personalize risk assessment for patients and relatives, as well as to individualize management regarding follow-up, treatment, and prophylactic and preventive measures. The group participates in international and national initiatives aimed to improve variant classification in hereditary cancer genes, define clinical guidelines for hereditary cancer patients, and implement genomic-based personalized medicine in the National Health System.
About the role
The postdoctoral researcher will be involved in the group's projects related to personalized medicine for patients with Neurofibromatosis type 1 (gene therapy, genotype-phenotype studies) under the supervision of the PI, although it is requested to collaborate in the rest of the different projects in progress in the laboratory, research activities and publications.
He/she will actively assist and implement new protocols to improve the primary schwannoma and stem cell culture techniques available in the laboratory, participate in research activities within the group and in team research publications.
He/she will interact with experts in medicine, genetics and bioinformatics to jointly evaluate the different designs, projects, protocols, results obtained, etc., participating in periodic group meetings to understand clinical and research needs and improve the experiments that are required.
Job requirements
Professional experience
- Experience in public research.
- Experience in collaborative projects with clinicians.
Education and training
- PhD in Life Science or equivalent (essential).
- Certificate to use experimental animals in research.
Technical & soft skills
- Advanced technical skills in laboratory work
- Advanced skills in cell culturing
- Advance skills in animal experimentation
- Competences: planning and organizational skills, communication, proactivity, problem-solving, teamwork.
Languages
- Good command of the English language
We will value, but not required
- Experience in human genetics and molecular biology (including cancer biology).
- Co-authorship in communications to meetings and publications.
- Experience in in vitro and in vivo preclinical trials.
- Experience in the usage of image processing program like ImageJ.
What do we offer
- No. of positions: 1
- Estimated start date: 01/01/2025
- Contract duration: 12 months
- Estimated annual gross salary: 35.000 €
- You will be part of a multicultural team. We have a fun loving and friendly international work environment.
- Flexible working schedule - We know you have a life outside of work and we will work with you to make sure it's kept that way.
- Possibility to work some days in remote -Teleworking
- 26 working days of holiday per year
- System of accumulated hours for employees, from 88 to 104 hours depending on the year (11 to 13 working days), to attend to personal matters.
- Paid leave package
- Benefits of constant training are offered
- We offer and promote diverse and inclusive conditions. Applicants are made free from any discrimination. Specifically IDIBELL works to improve gender equality in all areas with the aim of achieving gender balance, but maintaining the most scrupulous respect to any choice at the level of gender identity. Please express yourself freely, safely and non-binarily, if that's the case.
Deadline: Please submit your application by 27/09/2024
Data protection notice
In compliance with the obligations established in the General Regulation of Data Protection (RGPD), which is the Regulation (EU) 2016/679 of the Parliament and of the Council, of April 27, 2016, and the Organic Law 3/2018, of December 5, Protection of Personal Data and guarantee of digital rights, it is reported that the Institut d'Investigació Biomèdica de Bellvitge (IDIBELL), CIF G58863317, with address Av. Granvia de l'Hospitalet, 199-203, 08908, L'Hospitalet de Llobregat, will process your personal data, as the controller, to apply for the position, maintain communication concerning the status of the candidature, to access the delivered CV; to compare that your data is in accordance with the offers announced by IDIBELL and to verify, where appropriate, that the information provided is accurate. You can find more information in our Privacy Policy at https://idibell.cat/en/privacy-policy-2/, request more information about the data processing carried out and exercise your rights of access, rectification, deletion, opposition, portability, limitation of processing by sending a request at email: dataprotection@idibell.cat. If you consider that you have not obtained satisfaction in exercising your rights, you may submit a claim to Catalan Data Protection Authority.
Our institute
IDIBELL is a research center that integrates the biomedical research of the Bellvitge University Hospital (HUB), the Catalan Institute of Oncology (ICO), and the University of Barcelona in the Bellvitge Campus (UB), and the Viladecans Hospital (HV). The research focuses of IDIBELL are cancer, neuroscience, translational medicine and regenerative medicine. Research, innovation and society are the pivots on which researchers work every day in order to improve the quality of life of citizens.
Observations:
The 'HR Excellence in Research' award represents IDIBELL’s commitment to the implementation of Human Resources policies, which oversee the attracting and development of talent in an open, transparent, and based on personal merit, in alignment with the principles of the European Charter for Researchers and the Code of Conduct for the Recruitment Researchers (Charter and Code).
IDIBELL is committed to the principles of the Code of Conduct for the Recruitment of Researchers of the European Commission and the implementation of open, transparent and merit-based recruitment (OTMR).
This contract is supported by the Gilbert Family Foundation. Award No. 521008